When Lower BMI Patients Might Benefit From GLP-1 Therapy People with lower BMIs may pursue GLP-1 medications for legitimate reasons beyond traditional weight loss: managing binge eating disorder, reducing visceral fat while preserving muscle with proper nutrition, improving metabolic health markers like insulin resistance or blood sugar variability, or addressing food noise and compulsive eating patterns
Semaglutide (Ozempic, Wegovy, Rybelsus) Semaglutide is the most widely prescribed GLP-1 receptor agonist, available as both injectable (Ozempic for diabetes, Wegovy for weight management) and oral (Rybelsus) formulations
Some examples are, eating too much or too little, eating highly processed or pre-packaged foods instead of home-cooked meals, and eating at times that are out of alignment with your bodys circadian rhythm
EGCG belongs to a class of compounds called catechins that are found in high amounts in tea leaves, berries, and cocoa
The potential antidepressant effect of antidiabetic agents: new insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase